Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
01 July 2020 | Story Thabo Kessah | Photo Supplied
Breathtaking views of the misty Bvumba mountains.

While the Afromontane Research Unit (ARU) will always have a core focus on the sustainable development of the Maloti-Drakensberg (Lesotho-South Africa), the Southern African region is also very important to the unit. The primary reason for this is that Southern African mountains – the most important water-production landscapes in our drought-prone region – have no collective voice for their sustainable management. As such, there is no regional science-policy-action pipeline to secure these mountains for interventions to ensure that they can still produce key ecosystem services under global change. This is in contrast to East Africa where there is a much better-established community of practice for the charismatic African giants such as Mount Kilimanjaro. 

ARU-Southern African collaboration
To this end, the Director of the ARU, Dr Ralph Clark, revealed that the ARU has close links with academics, practitioners, and lay experts in Zimbabwe for the careful documenting of mountain biodiversity in the Manica Highlands. This is a trans-national mountain system critical for water supply to both Zimbabwe and Mozambique. The Bvumba (‘mist’ in Shona) Mountains are situated in the centre of the Manica Highlands. The name Bvumba is derived from the regular mist covering these mountains.

“The Bvumba has a complex socio-political history extending far back, before the arrival of the Portuguese in the 1400s. Despite this history of human occupation, and despite a century of botanical exploration in the 20th century, a comprehensive list of plant species – including endemic species – has never been published for the Bvumba. Such basic lists are essential for foundational knowledge that can drive sustainable development and responsible management of natural resources,” Dr Clark said.

The ARU and partners have collaborated to compile records of the first comprehensive species list for the Bvumba. “This project was done in partnership with the Harare Herbarium, Belgium’s Meise Botanical Gardens, the Flora of Zimbabwe and Mozambique projects, the Biodiversity Foundation for Africa, and the UK’s Royal Botanical Gardens, Kew. It was recently completed with a publication in the journal PhytoKeys.”

Bvumba’s hundreds of species
The Bvumba has a plant species complement of 1 127 native taxa in an area of only 276 square kilometres. “There is remarkable fern and orchid diversity in these mountains, with 137 fern species that is considered to be the richest fern locality in Southern Africa.  There are also 125 orchid species that make it exceptionally rich for this group. The only local Bvumba endemic is a critically endangered epiphytic forest orchid. Six other near-endemic plant taxa occur in the Bvumba, all of which are endemic to the Manica Highlands from Nyanga to Chimanimani,” added Dr Clark.

Low levels of local endemism are likely to be an effect of the Bvumba having limited natural grassland compared to forest. “Second to fynbos, grassland is the most endemic-rich habitat in Southern African mountains. Montane forests are poor in local endemics by comparison, which is contrary to what many would suppose. As in mountains across Southern Africa, invasive species are a major risk to water security, biodiversity conservation and livelihoods. The Bvumba is no exception, with Australian blackwood (Acacia melanoxylon), ginger lily (Hedychium gardnerianum), and bee bush (Vernonanthura polyanthes) being the most problematic species of the 123 naturalised introductions. While the Zimbabwean side of the Bvumba is the best explored, the Mozambican side of Serra Vumba offers exciting opportunities for further botanical research,” he emphasised.

News Archive

HIV Cure – Just another fantasy?
2016-07-27

Description: HIV Cure – Just another fantasy? Tags: HIV Cure – Just another fantasy?

Dr Dominique Goedhals, Prof John Frater,
Dr Thabiso Mofokeng and Dr Jacob Jansen van Vuuren,
attended the lecture. Prof Frater has been working in
collaboration with the UFS Department of Internal
Medicine on HIV resistance and HIV immunology
since 2007.

Photo: Nonsindiso Qwabe

Twenty-years ago, after a person had been diagnosed with HIV, their lifespan did not exceed three years, but thanks to the success of antiretroviral therapy programmes, life expectancy has risen by an average of ten years. However, is antiretroviral therapy always going to be for life? This is the societal issue that Professor John Frater, addressed in his talk at the University of the Free State. He is an MRC Senior Clinical Fellow, Associate Professor and Honorary Consultant Physician in Infectious Diseases at  Oxford University.

Antiretroviral medicine therapeutic

The discovery of antiretroviral therapy - the use of HIV medicines to treat the virus - has had a positive effect on the health and well-being of people living with it, improving their quality of life. Unfortunately, if treatment is stopped, HIV rebounds to the detriment of the patient. Now, research has shown that some patients, who are treated soon after being infected by HIV, may go off treatment for prolonged periods. Work is being done to predict who will be able to stop treatment.

“The difference made by starting treatment earlier is enormous. Delaying treatment is denying yourself the right to health,” Professor Frater says. However, this does not mean that the virus is cured. “A person can live for ten years without being on HIV treatment, but is that enough?” he went on to ask.

Healthy lifestyles encouraged

The National Department of Health will adopt a test and treat immediately strategy later this year to improve patient health and curb the spread of HIV. ,This is another reason why everybody should know their status and start treatment as soon as possible.

Search for a cure continues

More research is being conducted to establish whether HIV can be eradicated. Remission gives hope that a permanent cure may be found eventually. “Will a cure for HIV ever be found? Time will tell,” he concluded.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept